BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Morscio J, Tousseyn T. Recent insights in the pathogenesis of post-transplantation lymphoproliferative disorders. World J Transplant 2016; 6(3): 505-516 [PMID: 27683629 DOI: 10.5500/wjt.v6.i3.505]
URL: https://www.wjgnet.com/2220-3230/full/v6/i3/505.htm
Number Citing Articles
1
Chi Yuen Cheung, Wing Hung Lau, Wah Cheuk. Epstein-Barr Virus–Associated Nodal Marginal Zone Lymphoma: Part of the Spectrum of Posttransplant Lymphoproliferative Disorder?International Journal of Surgical Pathology 2019; 27(1): 94 doi: 10.1177/1066896918784184
2
Ayumi Fujimoto, Ritsuro Suzuki. Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disorders after Hematopoietic Stem Cell Transplantation: Pathogenesis, Risk Factors and Clinical OutcomesCancers 2020; 12(2): 328 doi: 10.3390/cancers12020328
3
Ingrid H Penzhorn, Johann W Schneider, Candice Sher-Locketz. The Prevalence of Epstein-Barr Virus in Plasma Cell Neoplasms is Higher in HIV-Positive IndividualsInternational Journal of Surgical Pathology 2023; 31(5): 564 doi: 10.1177/10668969221113490
4
Irina Margaritescu, Aurel-Doru Chirita, Kristen Addis, Matthew S. Dinehart, Sarah Carlock, Mallory Shiver Abate, Bruce R. Smoller. Atlas of Dermatology, Dermatopathology and Venereology2020; : 1 doi: 10.1007/978-3-319-45134-3_83-1
5
Duaa AbdelHameid, Anthony Felice, Lauren B. Cooper, Shalika B. Katugaha. Long‐term remission in an adult heart transplant recipient with advanced Burkitt’s lymphoma post‐transplant lymphoproliferative disorder after anthracycline‐free chemotherapy: A case report and literature reviewTransplant Infectious Disease 2020; 22(4) doi: 10.1111/tid.13265
6
Jonathan R Kerr. Epstein-Barr virus (EBV) reactivation and therapeutic inhibitorsJournal of Clinical Pathology 2019; 72(10): 651 doi: 10.1136/jclinpath-2019-205822
7
Ryan J. Stubbins, Ryan Lam, James Zhu, Sunita Ghosh, Curtis Mabilangan, John Kuruvilla, Rashmi S Goswami, Raymond Lai, Jutta K Preiksaitis, Michael D Jain, Anthea C Peters. Tumor Infiltrating Lymphocytes Predict Survival in Solid Organ Transplant Recipients With Monomorphic Post-transplant Lymphoproliferative DisordersClinical Lymphoma Myeloma and Leukemia 2022; 22(10): 744 doi: 10.1016/j.clml.2022.05.006
8
Rabea Asleh, Darko Vucicevic, Tanya M. Petterson, Walter K. Kremers, Naveen L. Pereira, Richard C. Daly, Brooks S. Edwards, D. Eric Steidley, Robert L. Scott, Sudhir S. Kushwaha. Sirolimus-Based Immunosuppression Is Associated with Decreased Incidence of Post-Transplant Lymphoproliferative Disorder after Heart Transplantation: A Double-Center StudyJournal of Clinical Medicine 2022; 11(2): 322 doi: 10.3390/jcm11020322
9
Mathis Overkamp, Massimo Granai, Irina Bonzheim, Julia Steinhilber, Jens Schittenhelm, Wolfgang Bethge, Leticia Quintanilla-Martinez, Falko Fend, Birgit Federmann. Comparative analysis of post-transplant lymphoproliferative disorders after solid organ and hematopoietic stem cell transplantation reveals differences in the tumor microenvironmentVirchows Archiv 2021; 478(6): 1135 doi: 10.1007/s00428-020-02985-4
10
Sergio Pina-Oviedo, Haitham A. Khogeer, Guilin Tang, Roberto N. Miranda. Oncological Surgical Pathology2020; : 1729 doi: 10.1007/978-3-319-96681-6_17
11
Heather Tillman, Peter Vogel, Tiffani Rogers, Walter Akers, Jerold E. Rehg. Spectrum of Posttransplant Lymphoproliferations in NSG Mice and Their Association With EBV Infection After Engraftment of Pediatric Solid TumorsVeterinary Pathology 2020; 57(3): 445 doi: 10.1177/0300985820913265
12
Britta Maecker-Kolhoff, Kais Hussein, Stephen Gottschalk. Pediatric Liver Transplantation2021; : 265 doi: 10.1016/B978-0-323-63671-1.00028-8
13
Upton D. Allen, Jutta K. Preiksaitis. Post‐transplant lymphoproliferative disorders, Epstein‐Barr virus infection, and disease in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of PracticeClinical Transplantation 2019; 33(9) doi: 10.1111/ctr.13652
14
由 李. Research Progress on EBV ReactivationAdvances in Clinical Medicine 2024; 14(03): 467 doi: 10.12677/ACM.2024.143725
15
Steven H. Swerdlow, Steven A. Webber. Post-Transplant Lymphoproliferative Disorders2021; : 9 doi: 10.1007/978-3-030-65403-0_2
16
Lukas Marcelis, Thomas Tousseyn. The Tumor Microenvironment in Post-Transplant Lymphoproliferative DisordersCancer Microenvironment 2019; 12(1): 3 doi: 10.1007/s12307-018-00219-5
17
Yuanyuan Yang, Wei Wang, Ying Kan, Jie Liu, Jigang Yang. FDG PET/CT Findings of Polymorphic Posttransplant Lymphoproliferative Disorders in a Transplanted KidneyClinical Nuclear Medicine 2018; 43(6): 441 doi: 10.1097/RLU.0000000000002027
18
Taigo Kato, Takahiro Yoshida, Ayumu Taniguchi, Masataka Kawamura, Shigeaki Nakazawa, Tomoko Namba‐Hamano, Kazuaki Yamanaka, Toyofumi Abe, Hidefumi Kishikawa, Norio Nonomura, Ryoichi Imamura. Incidence and mortality of post‐transplant lymphoproliferative disorders after kidney transplantation: A real‐world retrospective analysis in JapanInternational Journal of Urology 2022; 29(3): 206 doi: 10.1111/iju.14750
19
Diagnostic Pathology: Cardiovascular2018; : 94 doi: 10.1016/B978-0-323-59560-5.50037-0
20
Lukas Marcelis, Charlien Berghen, Alexandra De Zutter, Pauline Biesemans, Peter Vandenberghe, Gregor Verhoef, Olivier Gheysens, Xavier Sagaert, Daan Dierickx, Thomas Tousseyn. Other immunomodulatory agent-related lymphoproliferative diseases: a single-center series of 72 biopsy-confirmed casesModern Pathology 2018; 31(9): 1457 doi: 10.1038/s41379-018-0054-2
21
Peter Sečník, Antonín Jabor, Petra Lavríková, Juraj Sečník, Pavlína Malíková, Eva Pokorná, Janka Franeková. Immunoglobulin abnormalities in 1677 solid organ transplant recipients. Implications for posttransplantation follow-up.Transplant Immunology 2019; 57: 101229 doi: 10.1016/j.trim.2019.101229
22
Charlotte Lees, Maher K. Gandhi. Post-Transplant Lymphoproliferative Disorders2021; : 39 doi: 10.1007/978-3-030-65403-0_4
23
Alexandra Butzmann, Kaushik Sridhar, Diwash Jangam, Hanbing Song, Amol Singh, Jyoti Kumar, Karen M. Chisholm, Benjamin Pinsky, Franklin Huang, Robert S. Ohgami. Mutations in JAK/STAT and NOTCH1 Genes Are Enriched in Post-Transplant Lymphoproliferative DisordersFrontiers in Oncology 2022; 11 doi: 10.3389/fonc.2021.790481
24
Irene Faravelli, Daniele Velardo, Manuel Alfredo Podestà, Claudio Ponticelli. Immunosuppression-related neurological disorders in kidney transplantationJournal of Nephrology 2021; 34(2): 539 doi: 10.1007/s40620-020-00956-1
25
Li Liu, Xuyan Zhang, Sizhou Feng. Epstein-Barr Virus-Related Post-Transplantation Lymphoproliferative Disorders After Allogeneic Hematopoietic Stem Cell TransplantationBiology of Blood and Marrow Transplantation 2018; 24(7): 1341 doi: 10.1016/j.bbmt.2018.02.026
26
Leticia Quintanilla-Martinez, Steven H Swerdlow, Thomas Tousseyn, Carlos Barrionuevo, Shigeo Nakamura, Elaine S. Jaffe. New concepts in EBV-associated B, T, and NK cell lymphoproliferative disordersVirchows Archiv 2023; 482(1): 227 doi: 10.1007/s00428-022-03414-4
27
Peter Sečník, Petra Lavríková, Lenka Hošková, Pavlína Malíková, Antonín Jabor, Janka Franeková. Free light chain and intact immunoglobulin abnormalities in heart transplant recipients: Two year follow-up timelines and clinical correlationsTransplant Immunology 2017; 41: 22 doi: 10.1016/j.trim.2017.01.003
28
Sherif A. Rezk, Xiaohui Zhao, Lawrence M. Weiss. Epstein-Barr virus (EBV)–associated lymphoid proliferations, a 2018 updateHuman Pathology 2018; 79: 18 doi: 10.1016/j.humpath.2018.05.020
29
Meryem Colak, Shakhnoza Sarzhanova, Zeynep Arzu Yegin, Zubeyde Nur Ozkurt, Isil Fidan, Gulendam Bozdayi. Determination and Role of Epstein-Barr Virus in Patients With Lymphoproliferative DisordersClinical Lymphoma Myeloma and Leukemia 2021; 21(5): e488 doi: 10.1016/j.clml.2021.01.023
30
Ranya Abdulovski, Dina L. Møller, Andreas D. Knudsen, Søren S. Sørensen, Allan Rasmussen, Susanne D. Nielsen, Neval E. Wareham. Early‐ and late‐onset posttransplant lymphoproliferative disorders among adult kidney and liver transplant recipientsEuropean Journal of Haematology 2022; 109(4): 343 doi: 10.1111/ejh.13815
31
Kenneth Ofori, Craig R. Soderquist, Vundavalli V. Murty, David Park, George Vlad, Rebecca J. Leeman‐Neill, Suzanne Lentzsch, Bachir Alobeid, Govind Bhagat. The clinical and pathological features of plasma cell myeloma post solid organ transplantationAmerican Journal of Hematology 2020; 95(12): 1531 doi: 10.1002/ajh.25988
32
Mario L. Marques-Piubelli, Yessenia I. Salas, Carlos Pachas, Renato Becker-Hecker, Francisco Vega, Roberto N. Miranda. Epstein–Barr virus-associated B-cell lymphoproliferative disorders and lymphomas: a reviewPathology 2020; 52(1): 40 doi: 10.1016/j.pathol.2019.09.006
33
Qin-Fen Xie, Ping Chen, Xin-Hua Chen, Ji-Min Liu, Jan Lerut, Shu-Sen Zheng. Gastrointestinal tract post-transplant lymphoproliferative disorder after liver transplantationHepatobiliary & Pancreatic Diseases International 2017; 16(5): 556 doi: 10.1016/S1499-3872(17)60063-8
34
Michael Spiegel, Arshdeep Gujral, Binuragi Barakoti, Evan Magaliff. Abatacept-Induced Posttransplant Lymphoproliferative Disorder–Like Syndrome Without a History of TransplantJCR: Journal of Clinical Rheumatology 2021; 27(8S): S488 doi: 10.1097/RHU.0000000000001180
35
Shivani Ghoshal. Renal and Electrolyte Disorders and the Nervous SystemCONTINUUM: Lifelong Learning in Neurology 2023; 29(3): 797 doi: 10.1212/CON.0000000000001286
36
F. Montes de Jesus, D. Dierickx, V. Vergote, W. Noordzij, R. A. J. O. Dierckx, C. M. Deroose, A. W. J. M. Glaudemans, O. Gheysens, T. C. Kwee. Prognostic superiority of International Prognostic Index over [18F]FDG PET/CT volumetric parameters in post-transplant lymphoproliferative disorderEJNMMI Research 2021; 11(1) doi: 10.1186/s13550-021-00769-8
37
Emanuele Nicastro, Lorenzo D’Antiga. Pediatric Hepatology and Liver Transplantation2019; : 593 doi: 10.1007/978-3-319-96400-3_34
38
J Tecklenborg, D Clayton, S Siebert, S M Coley. The role of the immune system in kidney diseaseClinical and Experimental Immunology 2018; 192(2): 142 doi: 10.1111/cei.13119
39
Víctor Vinuesa, Carlos Solano, Estela Giménez, David Navarro. Comparison of the artus Epstein–Barr virus (EBV) PCR kit and the Abbott RealTime EBV assay for measuring plasma EBV DNA loads in allogeneic stem cell transplant recipientsDiagnostic Microbiology and Infectious Disease 2017; 88(1): 36 doi: 10.1016/j.diagmicrobio.2017.02.010
40
Hong Song, Kip E. Guja, Andrei Iagaru. 18F-FDG PET/CT for Evaluation of Post-Transplant Lymphoproliferative Disorder (PTLD)Seminars in Nuclear Medicine 2021; 51(4): 392 doi: 10.1053/j.semnuclmed.2020.12.009
41
Laura N. Walti, Catrina Mugglin, Daniel Sidler, Matteo Mombelli, Oriol Manuel, Hans H. Hirsch, Nina Khanna, Nicolas Mueller, Christoph Berger, Katia Boggian, Christian Garzoni, Dionysios Neofytos, Christian van Delden, Cédric Hirzel. Association of antiviral prophylaxis and rituximab use with posttransplant lymphoproliferative disorders (PTLDs): A nationwide cohort studyAmerican Journal of Transplantation 2021; 21(7): 2532 doi: 10.1111/ajt.16423
42
Fernando Warley, Federico Jauk, Victoria Otero, Hernán García Rivello. Single-center “Argentine” analysis of post-transplant lymphoproliferative disorders: incidence, histopathological characteristics and EBV statusHematology, Transfusion and Cell Therapy 2023; 45: S119 doi: 10.1016/j.htct.2022.08.005
43
Xiaohong Zhang, Wenge Hao, Tao Xu, Sha Liu, Hua Jiang. Diagnosis and treatment of neoplastic post-transplant lymphoproliferative disorder following hematopoietic stem cell transplant in β-thalassemiaMedicine 2017; 96(52): e9055 doi: 10.1097/MD.0000000000009055
44
Vibeke K. J. Vergote, Christophe M. Deroose, Steffen Fieuws, Wim Laleman, Ben Sprangers, Anne Uyttebroeck, Johan Van Cleemput, Gregor Verhoef, Robin Vos, Thomas Tousseyn, Daan Dierickx. Characteristics and Outcome of Post-Transplant Lymphoproliferative Disorders After Solid Organ Transplantation: A Single Center Experience of 196 Patients Over 30 YearsTransplant International 2022; 35 doi: 10.3389/ti.2022.10707
45
Xavier Mariette, Connie Chen, Pinaki Biswas, Kenneth Kwok, Mary G. Boy. Lymphoma in the Tofacitinib Rheumatoid Arthritis Clinical Development ProgramArthritis Care & Research 2018; 70(5): 685 doi: 10.1002/acr.23421
46
Mohit Agarwal, Seyed Ali Nabavizadeh, Suyash Mohan. Chapter 6 Non–Squamous Cell Causes of Cervical LymphadenopathySeminars in Ultrasound, CT and MRI 2017; 38(5): 516 doi: 10.1053/j.sult.2017.05.006
47
Claudio Annaloro, Fabio Serpenti, Giorgia Saporiti, Giulia Galassi, Francesca Cavallaro, Federica Grifoni, Maria Goldaniga, Luca Baldini, Francesco Onida. Viral Infections in HSCT: Detection, Monitoring, Clinical Management, and Immunologic ImplicationsFrontiers in Immunology 2021; 11 doi: 10.3389/fimmu.2020.569381
48
Experimental and Clinical Transplantation 2017; 15(Suppl 2) doi: 10.6002/ect.TOND16.L22
49
Sherif A. Rezk, Lawrence M. Weiss. EBV–Associated Lymphoproliferative DisordersSurgical Pathology Clinics 2019; 12(3): 745 doi: 10.1016/j.path.2019.03.002
50
Laura J. Janke, Denise M. Imai, Heather Tillman, Rosalinda Doty, Mark J. Hoenerhoff, Jiajie J. Xu, Zachary T. Freeman, Portia Allen, Natalie Wall Fowlkes, Ilaria Iacobucci, Kirsten Dickerson, Charles G. Mullighan, Peter Vogel, Jerold E. Rehg. Development of Mast Cell and Eosinophil Hyperplasia and HLH/MAS-Like Disease in NSG-SGM3 Mice Receiving Human CD34+ Hematopoietic Stem Cells or Patient-Derived Leukemia XenograftsVeterinary Pathology 2021; 58(1): 181 doi: 10.1177/0300985820970144
51
Irina Margaritescu, Aurel-Doru Chirita, Kristen Addis, Matthew S. Dinehart, Sarah Carlock, Mallory Shiver Abate, Bruce Smoller. Atlas of Dermatology, Dermatopathology and Venereology2022; : 477 doi: 10.1007/978-3-319-53805-1_83
52
Agata M. Bogusz. EBV-Negative Monomorphic B-Cell Posttransplant Lymphoproliferative Disorder with Marked Morphologic Pleomorphism and Pathogenic Mutations in ASXL1, BCOR, CDKN2A, NF1, and TP53Case Reports in Hematology 2017; 2017: 1 doi: 10.1155/2017/5083463
53
Lorenzo Zaffiri, Courtney Frankel, Erika J. Bush, Megan L. Neely, Elizabeth N. Pavlisko, Irina L. Mokrova, Micah A. Luftig, Scott M. Palmer. Evidence of Epstein‐Barr virus heterogeneous gene expression in adult lung transplant recipients with posttransplant lymphoproliferative disorderJournal of Medical Virology 2021; 93(8): 5040 doi: 10.1002/jmv.26936
54
Thomas Sommermann, Tomoharu Yasuda, Jonathan Ronen, Tristan Wirtz, Timm Weber, Ulrike Sack, Rebecca Caeser, Jingwei Zhang, Xun Li, Van Trung Chu, Anna Jauch, Kristian Unger, Daniel J. Hodson, Altuna Akalin, Klaus Rajewsky. Functional interplay of Epstein-Barr virus oncoproteins in a mouse model of B cell lymphomagenesisProceedings of the National Academy of Sciences 2020; 117(25): 14421 doi: 10.1073/pnas.1921139117
55
Stefano Fratoni, Justine M. Aziz, Carlo Gazia, Giuseppe Orlando, Andrea Tendas. Transplantation of the Pancreas2023; : 615 doi: 10.1007/978-3-031-20999-4_46